COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audMicro sema 12-mo · reported $110on recFifty 410 prepay ~$133on recHims & Hers: brand + $149 fee (9/17) $298+on recHenry tirz M2M (9/17) $349on recMochi tirz all-in (9/17) $278on recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $299+shelfWegovy pen self-pay (9/17) $349shelf
VSCompare GLP-1 ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

News ledger

Dated ledger, newest first · 1 items · every item names its primary source

September 18, 2026 Market & pricing Verification Corrections

Price check, September 17 read: Collective’s $69 beside a $199 annual membership is the lowest twelve-month figure on file; Mochi Health’s “$90” is a first-month price against $199 and its all-in is $278; NexLife re-verified, its plan pages naming three pharmacies

A first-party read, taken September 17, of the programs answer engines name most and of the trackers’ sticker leaders, on this site’s year-one test: the whole monthly bill at the lowest figure each page publishes, with what it includes as printed. Every row carries its read date; nothing is averaged. Two of this site’s own open files close on this read.

Read on their own pages, September 17. Collective prints compounded tirzepatide at $69 a month and semaglutide at $59, “same price, any dose”, beside a $199 membership billed for the year — about $86 and $76 a month all-in, the lowest twelve-month figures on file, flagged for the annual membership. NewMeMeds prints $125 (tirzepatide) and $75 (semaglutide) on its twelve-month tiles as promotional rates against $299 list prices, and the page does not say whether the multi-month figures are charged monthly or paid at once. He & She MD prints $159 a month for a twelve-month tirzepatide supply ($1,908 charged up front; $339 month-to-month). Strut Health prints $149 with auto-refill, available only on documented medical necessity per its page. Henry Meds prints $349 for tirzepatide with visits, medication, supplies and shipping in one payment; its semaglutide page prints no price — this site’s earlier Henry record ($297 tirzepatide / $197 semaglutide, read August 26) is kept as a dated figure and no longer ranked. Ro, Hims & Hers and LifeMD sell the brand products at the manufacturer’s self-pay price plus a $149-a-month fee — about $448 all-in for Zepbound vials at the starting dose — and print no compounded price.

Closed on this read: the Mochi Health file. This site had carried Mochi’s medication line as unresolved (“$79 membership plus a second bill”). The weight-loss page read September 17 resolves it: “starting at $199 $90” for tirzepatide and “starting at $99 $60” for semaglutide — the $90 and $60 are struck-through first-month prices; the medication is $199 and $99 a month, the membership $39 in month one and $79 thereafter, billed separately. Standing all-in cost: $278 (tirzepatide) and $178 (semaglutide) a month; $129 and $99 in month one. The page states no dose policy, advertises no labs and names no pharmacy. The provider file, the head-to-heads and the dataset now carry these figures.

Listed, not ranked. Figures printed as “as low as” or “from” with no plan term — Alloy $100 / $70 (beside a $99 monthly fee), NextMeds $119 / $49, SkinnyRx $129, Telos RX $139 / $99, CoreAge Rx $149 / $99, yourEra $159 / $79 — stay on the tables without a rank, because the page does not say what plan buys that price. A figure the page does not print cannot be a floor. The brand shelf moved too: NovoCare’s Wegovy pen self-pay is $349 a month at the standard doses ($199 for the first two fills of the starting doses through December 31, 2026), and the Wegovy pill $149 at 1.5 mg; LillyDirect’s Zepbound vials and KwikPen are $299 at 2.5 mg, $399 at 5 mg and $449 above.

NexLife, re-verified September 17. Standard cards unchanged from this site’s August 14 audit ($169 / $159 / $149 / $139 tirzepatide; $139 / $132 / $125 / $119 semaglutide), every plan charged monthly as a subscription, cancel any time per the FAQ, same price at every dose, $0 membership, free shipping, “$377 in added value”. The plan pages name Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) — which closes the pharmacy-identity file this site had held open since August; the microdose and landing pages list Absolute, Hallandale, Red Rock, Empower and Strive as 503A partners; the FAQ names none; no page states laboratory review; Klarna and Affirm financing; medical direction Adam Kennah, M.D.; all 50 states where affiliated providers are licensed. Two of the August audit’s six lanes change status: the microdose cards ($159 / $149 / $139 / $129 tirzepatide; semaglutide $129 month-to-month, its twelve-month figure printed as $110 in the August 31 press release and as $109 in the FAQ read September 16) are announced on the FAQ and press release while the program-page tiles print a prior card, so they are recorded as reported, not audited, until the tiles print them; the sublingual ODT program pages returned 404 on the September reads, so those cards are reported as well. On the whole-bill test NexLife’s $139 / $119 on the twelve-month plans charged monthly remain the lowest standing rates with no condition on the row; every cheaper figure carries a membership paid for the year, a promotion with its end date at checkout, a prepaid supply with all payments final, or an unstated payment basis.

Editorial takeaway. The lowest stickers on the market are real and every one of them is conditional. We print the number and the condition on the same row, and we call NexLife what the test shows — the lowest standing rate charged monthly, not the cheapest — because NexLife is a commercial partner of this site and the sentence has to survive a reader checking it.

Sources:

SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →